Guest Episode

Cardiovascular disease and why we should change the way we assess risk

Ep. #185 with Allan Sniderman, M.D.

AMA

GLP-1 Agonists - The Future of Treating Obesity?

Ep. #184 (AMA #29)

Guest Episode

Psychedelics & Recreational Drugs

Ep. #182 with David Nutt, DM, FRCP, FRCPsych, FSB, FMedSci

Guest Episode

Viewing cancer through an evolutionary lens and why this offers a radically different approach to treatment

Ep. #181 with Robert Gatenby, M.D.

AMA

All things testosterone and testosterone replacement therapy

Ep. #180 (AMA #28)

Guest Episode

The development of cancer immunotherapy and its promise for treating advanced cancers

Ep. #177 with Steven Rosenberg, M.D., Ph.D

Free Article

Does low cholesterol cause cognitive impairment? Part II

Free Article

Does low cholesterol cause cognitive impairment? Part I

Guest Episode

The biology of aging, rapamycin, and other interventions that target the aging process

Ep. #175 with Matt Kaeberlein, Ph.D.

Free Article

Rapamycin risks?

Free Article

Funding geroscience; suggested podcast listening

AMA

Continuous glucose monitors, zone 2 training, and a framework for interventions

Ep. #173 (AMA #26)

Free Article

How long can we live?; suggested listening

Free Article

A hope for treating Alzheimer’s disease?

Guest Episode

Diagnosing, preventing, and treating Alzheimer’s disease, and what we can all learn from patients with dementia

Ep. #164 with Amanda Smith, M.D.

Free Article

MDMA for PTSD?

Free Article

Psilocybin for depression?

Guest Episode

The latest on COVID-19 vaccines and their safety, herd immunity, and viral variants

Ep. #160 with Paul Offit, M.D.

Guest Episode

Evolution of the anti-vaccine movement, the causes of autism, and COVID-19 vaccine state of affairs

Ep. #159 with Peter Hotez, M.D., Ph.D.

Guest Episode

Scientific fraud—exposing Andrew Wakefield and the origin of the belief that vaccines cause autism

Ep. #158 with Brian Deer

Free Article

mRNA vaccine technology

Free Article

Metformin and COVID-19 mortality risk; a timeline of Kobe’s last day

Free Article

Promise and challenges for psilocybin and MDMA use in treatment

Free Article

A win for Topo Chico; COVID-19 vaccine second dose